Vis enkel innførsel

dc.contributor.authorTangen, Jon-Magnus
dc.contributor.authorHolien, Toril
dc.contributor.authorMirlashari, Mohammad Reza
dc.contributor.authorMisund, Kristine
dc.contributor.authorHetland, Geir
dc.date.accessioned2018-08-24T11:41:48Z
dc.date.available2018-08-24T11:41:48Z
dc.date.created2018-01-19T12:00:40Z
dc.date.issued2017
dc.identifier.citationBioMed Research International. 2017, 2017 .nb_NO
dc.identifier.issn2314-6133
dc.identifier.urihttp://hdl.handle.net/11250/2559235
dc.description.abstractAgaricus blazei Murill is an edible mushroom of the Basidiomycetes family, which has been found to contain a number of compounds with antitumor properties, such as proteoglycans and ergosterol. In the present investigation, we show that the commercial mushroom product Andosan, which contains 82.4% Agaricus blazei Murill, together with medicinal mushrooms Hericium erinaceus (14.7%) and Grifola frondosa (2.9%), has a cytotoxic effect on primary myeloma cells, other myeloma cell lines, and leukemia cell lines in vitro. Although the exact content and hence the mechanisms of action of the Andosan extract are unknown, we have found in this investigation indications of cell cycle arrest when myeloma cell lines are cultivated with Andosan. This may be one of the possible explanations for the cytotoxic effects of Andosan.nb_NO
dc.language.isoengnb_NO
dc.publisherHindawi Publishing Corporationnb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleCytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the Agaricus blazei Murill Based Mushroom Extract, Andosan™nb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber7nb_NO
dc.source.volume2017nb_NO
dc.source.journalBioMed Research Internationalnb_NO
dc.identifier.doi10.1155/2017/2059825
dc.identifier.cristin1547361
dc.description.localcode© 2017 Jon-Magnus Tangen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.nb_NO
cristin.unitcode194,65,15,0
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal